Journal article
Optimisation of Perioperative Cardiovascular Management to Improve Surgical Outcome II (OPTIMISE II) trial: Study protocol for a multicentre international trial of cardiac output-guided fluid therapy with low-dose inotrope infusion compared with usual care in patients undergoing major elective gastrointestinal surgery
MR Edwards, G Forbes, N MacDonald, V Berdunov, B Mihaylova, P Dias, A Thomson, MPW Grocott, MG Mythen, MA Gillies, M Sander, TD Phan, L Evered, DN Wijeysundera, SA McCluskey, C Aldecoa, J Ripollés-Melchor, CK Hofer, H Abukhudair, W Szczeklik Show all
BMJ Open | BMJ PUBLISHING GROUP | Published : 2019
Abstract
Introduction: Postoperative morbidity and mortality in older patients with comorbidities undergoing gastrointestinal surgery are a major burden on healthcare systems. Infections after surgery are common in such patients, prolonging hospitalisation and reducing postoperative short-term and long-term survival. Optimal management of perioperative intravenous fluids and inotropic drugs may reduce infection rates and improve outcomes from surgery. Previous small trials of cardiac-output-guided haemodynamic therapy algorithms suggested a modest reduction in postoperative morbidity. A large definitive trial is needed to confirm or refute this and inform widespread clinical practice. Methods: The Op..
View full abstractGrants
Funding Acknowledgements
The OPTIMISE II trial is supported by Edwards Lifesciences (Irvine, CA) and the UK National Institute for Health Research through RMP's NIHR Professorship.